M-MONTELUKAST

mantra pharma inc🇨🇦 Health Canada

Approval Id: e4b0a121638db96c
Drug Approval Canada Name: M-MONTELUKAST
Product Name: M-MONTELUKAST
Status: Marketed
Status Date: 2024-12-23
Original Market Date: 2019-12-13
Din: 02488183
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 48:10.24
Atc Original: R03DC03 MONTELUKAST
Atc Name: r 03 dc 03
Aig Number: 0133823002
Company Name: mantra pharma inc
Company Address: 1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3

MONTELUKAST (MONTELUKAST SODIUM)

10 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

e4b0a121638db96c

Type

Standard